Understanding regulatory preferences for GMOs and nanotechnology in USA, Israel, and Germany
Science and Public Policy · 31.10.2026
DOI: 10.1093/scipol/scag091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science and Public Policy, online erschienen am 31.10.2026. Verfasst von Shira Bukchin-Peles und 3 weiteren Autor:innen. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Emerging technologies such as genetically modified organisms (GMOs) and nanotechnology are widely regarded as central to future economic growth, social progress, and environmental sustainability, particularly in industrialized countries. Yet they also raise concerns about potential health, environmental, and safety risks. This study investigates public regulatory preferences for GMOs and nanotechnology in the USA, Israel, and Germany, based on a cross-national online panel survey. We identify notable differences in attitudes: participants strongly favour hard regulation for GMOs, while support for similar regulation of nanotechnology is significantly weaker. These differences reflect both perceived risk levels and broader national contexts. Our findings underscore the need for regulatory approaches that are both technology-specific and context-sensitive, recognizing that public acceptance is shaped by the cultural and institutional environments in which technologies are introduced.
Zitieren
APA
Bukchin-Peles, S., Wurster, S., Justo-Hanani, R., & Kurz, F. (2026). Understanding regulatory preferences for GMOs and nanotechnology in USA, Israel, and Germany. Science and Public Policy. https://doi.org/10.1093/scipol/scag091
Vancouver
Bukchin-Peles S, Wurster S, Justo-Hanani R, Kurz F. Understanding regulatory preferences for GMOs and nanotechnology in USA, Israel, and Germany. Science and Public Policy. 2026. doi:10.1093/scipol/scag091
BibTeX
@article{BukchinPeles2026,
author = {Bukchin-Peles, Shira and Wurster, Stefan and Justo-Hanani, Ronit and Kurz, Felix},
title = {Understanding regulatory preferences for GMOs and nanotechnology in USA, Israel, and Germany},
journal = {Science and Public Policy},
year = {2026},
doi = {10.1093/scipol/scag091}
}
EUVIMED